Echocardiographic diastolic function evolution in patients with an anterior Q-wave myocardial infarction: insights from the REVE-2 study.
Adult
Aged
Anterior Wall Myocardial Infarction
/ blood
Blood Proteins
Diastole
Echocardiography
/ methods
Electrocardiography
Female
Follow-Up Studies
Galectin 3
/ blood
Galectins
Humans
Male
Middle Aged
Natriuretic Peptide, Brain
/ blood
Prospective Studies
Stroke Volume
/ physiology
Time Factors
Ventricular Function, Left
/ physiology
Ventricular Remodeling
Cardiac remodelling
Collagen peptides
Diastolic dysfunction
Galectin-3
Myocardial infarction
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
17
01
2018
revised:
21
05
2018
accepted:
30
08
2018
pubmed:
22
11
2018
medline:
16
3
2019
entrez:
22
11
2018
Statut:
ppublish
Résumé
Myocardial fibrosis plays a key role in the development of adverse left ventricular remodelling after myocardial infarction (MI). This study aimed to determine whether the circulating levels of BNP, collagen peptides, and galectin-3 are associated with diastolic function evolution (both deterioration and improvement) at 1 year after an anterior MI. The REVE-2 is a prospective multicentre study including 246 patients with a first anterior Q-wave MI. Echocardiographic assessment was performed at hospital discharge and ±1 year after MI. BNP, galectin-3, and collagen peptides were measured ±1 month after MI. Left ventricular diastolic dysfunction (DD) was defined according to the presence of at least two criteria of echocardiographic parameters: septal e' < 8 cm/s, lateral e' < 10 cm/s, and left atrial volume ≥ 34 mL/m The present study suggests that circulating levels of amino-terminal propeptide of type III procollagen, galectin-3, and BNP may be independently associated with new-onset DD in post-MI patients.
Identifiants
pubmed: 30460754
doi: 10.1002/ehf2.12359
pmc: PMC6351891
doi:
Substances chimiques
Blood Proteins
0
Galectin 3
0
Galectins
0
LGALS3 protein, human
0
Natriuretic Peptide, Brain
114471-18-0
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
70-79Informations de copyright
© 2018 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.
Références
Clin Chem. 2005 May;51(5):925-6
pubmed: 15855677
Hypertension. 2012 Jun;59(6):1179-87
pubmed: 22547442
Am J Epidemiol. 2007 Mar 15;165(6):710-8
pubmed: 17182981
Am J Cardiol. 2010 Nov 15;106(10):1410-6
pubmed: 21059429
Circulation. 2009 May 12;119(18):2471-9
pubmed: 19398668
Am J Cardiol. 2006 Nov 1;98(9):1144-9
pubmed: 17056315
Circulation. 2003 May 27;107(20):2559-65
pubmed: 12732605
Hypertension. 2015 Nov;66(5):961-9
pubmed: 26351031
ESC Heart Fail. 2019 Feb;6(1):70-79
pubmed: 30460754
Circ Heart Fail. 2013 Nov;6(6):1199-205
pubmed: 23983248
Int J Cardiol. 2011 Aug 4;150(3):277-82
pubmed: 20493567
Int J Mol Sci. 2017 Jul 31;18(8):
pubmed: 28758988
J Cardiovasc Ultrasound. 2015 Sep;23(3):150-7
pubmed: 26448823
Immunol Rev. 2009 Jul;230(1):160-71
pubmed: 19594635
JACC Heart Fail. 2014 Oct;2(5):541-3
pubmed: 25301159
Eur J Heart Fail. 2015 Feb;17(2):214-23
pubmed: 25418979
Int J Cardiol. 2011 Sep 15;151(3):387-8
pubmed: 21783267
Clin Res Cardiol. 2018 Jan;107(1):49-59
pubmed: 28852839
PLoS One. 2014 Sep 02;9(9):e95254
pubmed: 25180794
J Am Coll Cardiol. 1985 Jun;5(6):1355-62
pubmed: 3158687
Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
Eur J Heart Fail. 2015 Apr;17(4):385-92
pubmed: 25684565
Hypertension. 2014 Apr;63(4):740-6
pubmed: 24446063
Circ Cardiovasc Imaging. 2009 May;2(3):191-8
pubmed: 19808592
J Am Coll Cardiol. 2017 Jun 27;69(25):3119-3121
pubmed: 28641802
Circulation. 2005 Nov 8;112(19):2940-5
pubmed: 16275882
Am J Epidemiol. 2013 Oct 15;178(8):1272-80
pubmed: 23997209
Eur Heart J. 2014 Sep 7;35(34):2295-302
pubmed: 24780614
Biochem Soc Trans. 2007 Nov;35(Pt 5):849-52
pubmed: 17956230
Circ Res. 1990 Oct;67(4):871-85
pubmed: 2145091
Circulation. 2017 Jan 31;135(5):426-439
pubmed: 27927714
J Am Soc Echocardiogr. 2009 Feb;22(2):107-33
pubmed: 19187853
Eur Heart J. 2014 Feb;35(6):395-402
pubmed: 24255130
Int J Obes (Lond). 2005 Nov;29(11):1321-8
pubmed: 16116494
JACC Heart Fail. 2015 Jan;3(1):50-58
pubmed: 25458175
Circulation. 2015 Feb 10;131(6):550-9
pubmed: 25552356
J Am Coll Cardiol. 2016 Apr 26;67(16):1917-27
pubmed: 27102506
Circulation. 1994 Jan;89(1):68-75
pubmed: 8281697
Circulation. 2006 Dec 12;114(24):2604-10
pubmed: 17116769
Cardiovasc Pathol. 2015 Jul-Aug;24(4):213-23
pubmed: 25547609
Circulation. 2006 Aug 1;114(5):438-44
pubmed: 16880341
Circ Heart Fail. 2013 Jan;6(1):107-17
pubmed: 23230309
Circulation. 1997 Oct 21;96(8):2565-72
pubmed: 9355895
Circulation. 1993 Jul;88(1):82-91
pubmed: 8319360
J Hypertens. 2018 Feb;36(2):368-376
pubmed: 28858976
Circulation. 2003 Sep 16;108(11):1395-403
pubmed: 12975244
Circ Cardiovasc Imaging. 2009 Nov;2(6):437-43
pubmed: 19920041
Am J Cardiol. 1995 May 1;75(14):913-8
pubmed: 7733000
Echocardiography. 2007 Sep;24(8):837-42
pubmed: 17767534